|
|
Nutrilib.com
A comprihensive source of nutritional information
|
|
COPAXONE SUMMARY
COPAXONE ®
(glatiramer acetate injection)
COPAXONE® is the brand name for glatiramer acetate (formerly known as copolymer-1). Glatiramer acetate, the active ingredient of COPAXONE®, consists of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine with an average molar fraction of 0.141, 0.427, 0.095, and 0.338, respectively.
COPAXONE® Injection is indicated for reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis.
|
COPAXONE NEWS HIGHLIGHTS Media Articles Related to Copaxone (Glatiramer)
Study Shows Shocking Cost Of Multiple Sclerosis
Source: Multiple Sclerosis News From Medical News Today [2008.11.25]
Multiple Sclerosis Trust Stresses The Importance Of Reliable Health Information
Source: Multiple Sclerosis News From Medical News Today [2008.11.20]
Relapsing-Remitting Multiple Sclerosis - Teva Completes Enrollment In Laquinimod Phase III Clinical Trial
Source: Multiple Sclerosis News From Medical News Today [2008.11.18]
Environment Causes Increase In Multiple Sclerosis Among Women Only
Source: Multiple Sclerosis News From Medical News Today [2008.11.17]
Sheffield Hallam University (UK) Explores Exercise Intervention For Multiple Sclerosis Sufferers
Source: Multiple Sclerosis News From Medical News Today [2008.11.17]
Published Studies Related to Copaxone (Glatiramer)
Impact of warm compresses on local injection-site reactions with self-administered glatiramer acetate. [2008.08]
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis. [2008.06]
Long-term (up to 22 years), open-label, compassionate-use study of glatiramer acetate in relapsing-remitting multiple sclerosis. [2008.05]
Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study. [2008.01]
Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers. [2007.08]
Clinical Trials Related to Copaxone (Glatiramer)
Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation [Active, not recruiting]
Treatment of Multiple Sclerosis With Copaxone and Albuterol [Active, not recruiting]
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis. [Completed]
CopaxoneŽ Study to Follow Patients From the First Original Study for Safety and Effectiveness. [Active, not recruiting]
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis [Completed]
|
COPAXONE PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 1 ratings/reviews, Copaxone has an overall score of 9. The effectiveness score is 8 and the side effect score is 8. The scores are on ten point scale: 10 - best, 1 - worst.
| | Copaxone review by 49 year old female patient | | | Rating |
| Overall rating: | |   |
| Effectiveness: | | Considerably Effective |
| Side effects: | | Mild Side Effects | | |
Treatment Info |
| Condition / reason: | | relapsing/remitting multiple sclerosis |
| Dosage & duration: | | 20 mg taken every day for the period of 7 years |
| Other conditions: | | osteoporosis, migraine headache, spastic bladder |
| Other drugs taken: | | Ditropan 15 mg, Wellbutrin 300 mg | | |
Reported Results |
| Benefits: | | It reduces the frequency of episodes of relapsing/remitting multiple sclerosis. |
| Side effects: | | The most common side effects are reactions at the injection site, which I have had, especially at the beginning of treatment. These are redness, a lump or firmness, soreness, or itching at the site of injection. Once I developed a permanent depression at an injection site, which is caused by a localized destruction of fat tissue. Some patients (I never have) develop a short term reaction experienced immediately after injecting this medicine. This reaction includes a feeling of warmth and/or redness known as flushing, chest tightness or pain with heart palpatations, anxiety, and trouble breathing. These symptoms may last a few minutes then go away by themselves without any further problems. Each package of Copaxone contains a complete list of possible side effects, or you may obtain this list from your doctor or pharmacist. |
| Comments: | | Each single use blister pack of Copaxone contains one prefilled syringe containing 20 mg of Copaxone (glatiramer acetate) which the patient self administers subcutaneously, in the fatty layer of skin, once a day. It is important to rotate injection sites daily. |
|
|
|
Page last updated: 2008-11-25
|
|
-- advertisement --
|
